Dana Investment Advisors, Inc. Laboratory Corp Of America Holdings Transaction History

Dana Investment Advisors, Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$209.01 - $232.56 $2.09 Million - $2.32 Million	9,993 New	9,993 $2.18 Million
Q4 2018 Feb 14, 2019	SELL	$120.82 - $174.09 $5.88 Million - $8.47 Million	-48,675 Closed	0 $0
Q3 2018 Nov 14, 2018	SELL	$167.67 - $188.27 $136,315 - $153,063	-813 Reduced 1.64%	48,675 $8.45 Million
Q2 2018 Aug 01, 2018	BUY	$160.33 - $189.41 $57,398 - $67,808	358 Added 0.73%	49,488 $0
Q1 2018 May 15, 2018	BUY	$161.53 - $178.11 $5.44 Million - $6 Million	33,699 Added 218.39%	49,130 $7.95 Million
Q4 2017 Feb 13, 2018	BUY	$147.99 - $163.95 $2.28 Million - $2.53 Million	15,431	15,431 $0

1.87M

Ticker LH
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 89,600,000
Market Cap $22.8B
Description
Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests,...

Get notified when there are updates to the investment portfolio of Dana Investment Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Dana Investment Advisors, Inc. with notifications on news.